Hematology Oncology Northwest, P.C.
Tacoma, Washington, United States
Oncologist in Tacoma, Washington
1624 S I St UNIT 102, Tacoma, WA 98405
About Hematology Oncology Northwest, P.C.
"Northwest Medical Specialties offers comprehensive cancer treatment that includes screening and treating breast cancer, skin cancer, kidney cancer, and more. We also treat infectious diseases such as sinusitis, skin infections, and bone infections."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hematology Oncology Northwest, P.C.
During the past decade, Hematology Oncology Northwest, P.C. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
2009-05-01
2013-01-01
Completed
2,120
Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
2011-10-01
2014-08-01
Completed
2,059
A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI
2012-09-01
2014-09-01
Completed
1,190
Study to Identify Factors Influencing Access of Pregnant Women and Their Infants to Local Healthcare Systems
2012-11-01
2015-01-01
Completed
3,243
Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses
2013-10-01
2014-09-01
Completed
456
The Evidence for Contraceptive Options and HIV Outcomes Trial
2015-12-14
2018-10-31
Completed
7,830
Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults
2016-12-07
2020-02-12
Completed
334
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hematology Oncology Northwest, P.C.
According to Clinical.Site data, the most researched conditions in "Hematology Oncology Northwest, P.C." are
"Multiple Myeloma and Plasma Cell Neoplasm" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "Hematology Oncology Northwest, P.C." in a lesser frequency.
Clinical Trials Intervention Types at Hematology Oncology Northwest, P.C.
Most popular intervention types in "Hematology Oncology Northwest, P.C." are "Biological" (1 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (1 trials), "Wobe-Mugos E" (1 trials), "melphalan" (1 trials), "prednisone" (1 trials) and "quality-of-life assessment" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hematology Oncology Northwest, P.C.
The vast majority of trials in "Hematology Oncology Northwest, P.C." are
1 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Hematology Oncology Northwest, P.C.
Currently, there are NaN active trials in "Hematology Oncology Northwest, P.C.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Hematology Oncology Northwest, P.C.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hematology Oncology Northwest, P.C., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".